Michael Rome
Directeur/Membre du Conseil chez Remix Therapeutics, Inc.
Profil
Michael Rome is currently the Director at Remix Therapeutics, Inc. and the Vice President at Foresite Life Sciences Corp.
He previously worked as the Director at Pharvaris NV from 2019 to 2020, Independent Director at Theseus Pharmaceuticals, Inc. from 2021 to 2024, Director & Vice President at FS Development Corp.
from 2020 to 2021, and Independent Director at Kinnate Biopharma, Inc. from 2019 to 2024.
Dr. Rome has an undergraduate degree from the University of California, Los Angeles and a doctorate degree from the California Institute of Technology.
Postes actifs de Michael Rome
| Sociétés | Poste | Début |
|---|---|---|
Foresite Life Sciences Corp.
 Foresite Life Sciences Corp. Financial ConglomeratesFinance Foresite Life Sciences Corp. is a blank check company formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. The company was founded in January 2021 and is headquartered in San Francisco, CA. | Corporate Officer/Principal | 01/01/2021 |
Remix Therapeutics, Inc.
 Remix Therapeutics, Inc. BiotechnologyHealth Technology Remix Therapeutics, Inc. operates as a biotechnology company. It involves in developing small molecule therapies which are designed to reprogram RNA processing to address the underlying drivers of disease. The company was founded by Pete Smith and is headquartered in Cambridge, MA. | Directeur/Membre du Conseil | - |
Anciens postes connus de Michael Rome
| Sociétés | Poste | Fin |
|---|---|---|
| KINNATE BIOPHARMA INC. | Directeur/Membre du Conseil | 03/04/2024 |
| THESEUS PHARMACEUTICALS, INC. | Directeur/Membre du Conseil | 14/02/2024 |
| FS DEVELOPMENT CORP. | Directeur/Membre du Conseil | 01/02/2021 |
| PHARVARIS N.V. | Directeur/Membre du Conseil | 31/12/2020 |
| PARDES BIOSCIENCES, INC. | Directeur/Membre du Conseil | - |
Formation de Michael Rome
| University of California, Los Angeles | Undergraduate Degree |
| California Institute of Technology | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| PHARVARIS N.V. | Health Technology |
| Entreprise privées | 6 |
|---|---|
FS Development Corp.
 FS Development Corp. Financial ConglomeratesFinance FS Development Corp. operates as a blank check company. It is for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. The company was founded by Jim Tananbaum in June 2020 and is headquartered in San Francisco, CA. | Finance |
Kinnate Biopharma, Inc.
 Kinnate Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Kinnate Biopharma, Inc. operates as a biopharmaceutical company engaged in the research and development of Kinnate Discovery Engine that targets genomic drivers of cancer. The company was founded by Stephen W. Kaldor and Eric A. Murphy in January 2018 and is headquartered in San Diego, CA. | Health Technology |
FS Development Corp. II
 FS Development Corp. II Financial ConglomeratesFinance FS Development Corp. II is a blank check company, which formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more entities. The company was founded by James B. Tananbaum on August 21, 2020 and is headquartered in Larkspur, CA. | Finance |
Theseus Pharmaceuticals, Inc.
 Theseus Pharmaceuticals, Inc. BiotechnologyHealth Technology Theseus Pharmaceuticals, Inc. engages in the development of pan-variant kinase inhibitors. It focuses on the discovery, development and commercialization of transformative targeted therapies. The company was founded by William C. Shakespeare, David C. Dalgarno, Iain D. Dukes, Wei Sheng Huang and Victor M. Rivera on December 29, 2017 and is headquartered in Cambridge, MA. | Health Technology |
Foresite Life Sciences Corp.
Foresite Life Sciences Corp. Financial ConglomeratesFinance Foresite Life Sciences Corp. is a blank check company formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. The company was founded in January 2021 and is headquartered in San Francisco, CA. | Finance |
Remix Therapeutics, Inc.
Remix Therapeutics, Inc. BiotechnologyHealth Technology Remix Therapeutics, Inc. operates as a biotechnology company. It involves in developing small molecule therapies which are designed to reprogram RNA processing to address the underlying drivers of disease. The company was founded by Pete Smith and is headquartered in Cambridge, MA. | Health Technology |
